This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
CMV Reactivation, Allogeneic Stem Cell Transplantation or Autologous CMV Specific CD8+ T Cells
and you are
over 18
years old
1
2
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The investigators will assess whether the infusion of autologous CMV-specific T-cells at the time of CMV reactivation posttransplant will prevent worsening of CMV virus reactivation posttransplant to a level that warrants therapy with antiviral drugs (objectively assessed by looking at CMV virus copy number).

Provided treatments

  • Procedure: Lymphopheresis
  • Procedure: CMV specific lymphocyte infusion
  • Procedure: Peripheral blood for CMV DNA PCR
  • Procedure: Haematology/Blood chemistry

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01326273. The sponsor of the trial is Imperial College London and it is looking for 0 volunteers for the current phase.
Official trial title:
Adoptive Transfer of Autologous CMV Specific CD8+ T Cells After Allogeneic Stem Cell Transplantationas Treatment for CMV Reactivation: A Phase I/II Clinical Trial.